Gsk (GSK) Current Taxes (2009 - 2026)
Gsk (GSK) posted quarterly Current Taxes of -$703.0 million for Q2 2026, up 9.29% year-over-year from -$643.3 million in Q2 2025, and up 6.04% quarter-over-quarter from -$748.2 million in Q1 2026.
Gsk (GSK) Current Taxes (2009 - 2026) Analysis & Trends
Gsk's Current Taxes history runs 18 years deep, the most recent figure standing at -$703.0 million for Q2 2026.
- In Q2 2026, Current Taxes rose 9.29% year-over-year to -$703.0 million; the TTM figure through Jun 2026 stood at -$703.0 million (up 9.29% YoY), while the FY2025 annual figure was -$656.6 million, down 173.07% from the prior year.
- Current Taxes for Q2 2026 stood at -$703.0 million, up from -$748.2 million in the prior quarter.
- The five-year high for Current Taxes was $902.3 million in Q4 2024, with the low at -$922.7 million in Q2 2024.
- The 5-year median for Current Taxes is -$588.9 million (2025), against an average of -$390.1 million.
- The sharpest annual moves came in 2022 and 2025: Current Taxes surged 84.62% in 2022, then tumbled 173.41% in 2025.
- Gsk's Current Taxes stood at $552.4 million in 2022, then rose by 12.33% to $620.6 million in 2023, then surged by 45.4% to $902.3 million in 2024, then sank by 173.41% to -$662.4 million in 2025, then decreased by 6.13% to -$703.0 million in 2026.
- Business Quant data shows GSK's Current Taxes at -$703.0 million in Q2 2026, -$748.2 million in Q1 2026, and -$662.4 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.03 Bn | 632.27 Bn | 17.26 Bn | 1.05 Bn |
| 2 | AbbVie | 469.62 Bn | 463.05 Bn | 12.70 Bn | - |
| 3 | Merck | 375.00 Bn | 367.85 Bn | 12.21 Bn | 4.22 Bn |
| 4 | Novartis Ag | 303.31 Bn | 295.62 Bn | 11.24 Bn | 2.31 Bn |
| 5 | Astrazeneca | 257.68 Bn | 252.78 Bn | 12.86 Bn | 1.47 Bn |
| 6 | Amgen | 236.34 Bn | 222.35 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 182.09 Bn | 178.91 Bn | 6.22 Bn | - |
| 8 | Pfizer | 159.43 Bn | 147.73 Bn | 10.94 Bn | 653.00 Mn |
| 9 | Gsk | 106.25 Bn | 102.08 Bn | 8.24 Bn | -703.04 Mn |
| 10 | Sanofi | 55.19 Bn | 47.81 Bn | 10.79 Bn | 1.03 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -703.04 Mn |
| Mar 31, 2026 | -748.24 Mn |
| Dec 31, 2025 | -662.42 Mn |
| Sep 30, 2025 | -437.19 Mn |
| Jun 30, 2025 | -775.08 Mn |
| Mar 31, 2025 | -790.97 Mn |
| Dec 31, 2024 | 902.30 Mn |
| Sep 30, 2024 | -738.00 Mn |
| Jun 30, 2024 | -922.68 Mn |
| Mar 31, 2024 | -913.33 Mn |
| Dec 31, 2023 | 620.58 Mn |
| Sep 30, 2023 | -362.27 Mn |
| Jun 30, 2023 | -680.74 Mn |
| Mar 31, 2023 | -515.38 Mn |
| Dec 31, 2022 | 552.45 Mn |
| Sep 30, 2022 | -152.03 Mn |
| Jun 30, 2022 | -371.50 Mn |
| Mar 31, 2022 | -324.72 Mn |
| Dec 31, 2021 | 659.18 Mn |
| Sep 30, 2021 | -988.44 Mn |